Harpoon Therapeutics
South San Francisco, CA
Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kil...Read more
harpoontx.comCompany Details
Founded
- 2015
Employees
- 53 employees
Raised
- $255,000,000
Headquarters Location
- South San Francisco, CA
Public
- Yes
Acquired
- Yes
CEO
Julie Eastland
Founders
- Patrick A. BaeuerleLuke Evnin
Company Collections
These are collections Harpoon Therapeutics is a part of. Click on the collection name to view similar companies.
Harpoon Therapeutics' Industries
Harpoon Therapeutics Headquarters Location
4000 Shoreline Ct suite 250, South San Francisco, CA 94080
Total Amount Raised: $255,000,000
Harpoon Therapeutics Funding Rounds
Post Ipo Equity
$100,000,000
Post Ipo Equity Investors
Lion Point CapitalSurveyor CapitalCommodore CapitalNew Leaf Venture PartnersAlly Bridge GroupCormorant Asset ManagementRA Capital ManagementSoleus CapitalInvusK2 HealthVenturesPost Ipo Equity
$25,000,000
Post Ipo Equity Investors
InvusOrbiMed AdvisorsArix BioscienceK2 HealthVenturesNew Leaf Venture PartnersIPO
Unknown
Series C
$70,000,000
Series C Investors
New Leaf Venture PartnersOrbiMed AdvisorsRidgeback Capital ManagementArix BioscienceTaiho VenturesMPM CapitalUBS Asset ManagementLilly Asia VenturesNS Investmentoncology impact fundSeries B
$45,000,000
Series B Investors
Arix BioscienceMPM CapitalNew Leaf Venture PartnersTaiho VenturesUBS Asset ManagementSeries A
$15,000,000
Series A Investors
MPM CapitalUBS Asset Management
Funding info provided by Diffbot.
Harpoon Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Harpoon Therapeutics.